Darlene Noci
Fortune : 6 M $ au 31/05/2026
Fortune : 6 M $ au 31/05/2026
Darlene Noci is the founder of Noci Strategic Consulting LLC, founded in 2018.
The current job is Chief Development Officer at Nuvalent, Inc., starting in 2022, with employment at Nuvalent beginning in 2021.
Former jobs include Head-Regulatory Affairs at AVEO Pharmaceuticals, Inc., VP-Regulatory Affairs & Quality Assurance at X4 Pharmaceuticals, Inc. from 2016 to 2018, and Principal at EMD Serono, Inc. from 2014 to 2016.
Education includes graduate studies at Harvard University and undergraduate studies at Adelphi University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,09 % | 28/05/2026 | 58 117 ( 0,09 % ) | 6 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NUVALENT, INC. | Corporate Officer/Principal | 20/07/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/05/2018 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01/01/2016 |
Noci Strategic Consulting LLC | Fondateur | - |
| AVEO PHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adelphi University
Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Nuvalent, Inc.
Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Noci Strategic Consulting LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national